Survival Outcomes in Patients With Previously Untreated BRAF Wild-Type Advanced Melanoma Treated With Nivolumab Therapy: Three-Year Follow-up of a Randomized Phase 3 Trial.

Name: Survival Outcomes in Patients With Previously Untreated BRAF Wild-Type Advanced Melanoma Treated With Nivolumab Therapy: Three-Year Follow-up of a Randomized Phase 3 Trial.
Author: Ascierto, Paolo A

Survival Outcomes in Patients With Previously Untreated BRAF Wild-Type Advanced Melanoma Treated With Nivolumab Therapy: Three-Year Follow-up of a Randomized Phase 3 Trial. — المؤلف: Ascierto, Paolo A — JAMA oncology 20191206

المؤلف: Ascierto, Paolo A
النشر: JAMA oncology 20191206
الوصف: 187-194 p.
الموضوعات: Adolescent؛ Adult؛ Aged؛ Aged, 80 and over؛ Antineoplastic Agents, Alkylating؛ Antineoplastic Agents, Immunological؛ Dacarbazine؛ Disease Progression